Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I see Eco's reply, but let me add that if approval was given and then follow up data sucked, the FDA would look like idiots. The fact that they want to see more, and the fact that the dosage for the next 500 are even stronger, makes me optimistic. With that said, today was not fun.
ps. We wait.
Dude- Your due diligence is appreciated and your knowledge is unrelenting. The only part I understood is when you said you don't have time to respond to the third prompt.
ps. I get the glutathione relevance, the NAC comparison, the lessening of myocardial repercussion, and a host of other positives, but what I think we need most is just plain and simple dumb luck. A few patients here could swing this at 210, so unblinding the rest seems to be in order. I trust the FDA will like the 210 to get us to the next phase. Wash, scrub, clean, prepare, and shoot that sh-t off now.
pps. Let's get em.
I am not even worried about it. If we drop, we are diverse enough to make it back to where most of us bought before long. However, this does seem like good news. It may even make our data look extra good in the eyes of the FDA. MF is locked and loaded with the next 500 if needed.
ps. Let's get em.
That's what I am thinking too. In other words, every single person that when through the trial has his data cleaned and is ready to be submitted based on FDA nod.
The Dales Report
@TheDalesReport
$RVVTF AGM just finished. Some key takeaways:
- Revive has 450-500 patient data scrubbed/ready to present to regulators as needed
- Capital raise possible if EP swap approved
- FDA should have EP decision in 30 days
- Clinical trial sites on standby if add-on patient data needed
Put me down for a few more shares.
You think there will be a bidder based on the 210 when 1/3 were placebo and at that stage 1/3 had the low dosage three times a day? I know it's 16X more powerful than NAC, but this sounds too risky for BP. Who knows? If they wait, maybe they will be too late. I'd like to see our statistician look at the 750 and then decide where we are. Likely, Revive would need some help with logistics or start up capital, but maybe we could get more for the offer when we have solid data with a larger sample size.
ps. I still have the 5,000,000,000 MOU from Supria on my mind.
pps. Let's get em.
From my expertise in clinical trials, it appears obvious that we are in the Type A -Let's Go Phase. The thirty day countdown has begun, This should be easy.
ps. Let's get em
Dude. I thought you were like Elvis and left the building. Next thing you know Blue will post too.
ps. Let's get em. (I hope this catches on)
I guess the elephant is no longer in the room. I try not to think of that trial because it's not really comparing apples to apples other than saying they were both trials. If not mistaken the gout trial was before MF became the big cheese. Regardless, I know we will have plenty of reporting here after the upcoming RVVTF meeting. My guess is news before the meeting. Let's hope for a homerun or better yet a grand slam.
ps. We wait as the clock is ticking.
I wish I had sources. I hope they are right because taking this long seems so wrong.
ps. We wait.
Thanks, buddy. Let's make some money on this thing.
Yes. The company still exists, and you will be rewarded for your patience. MF is in the process of a big move to the states and---- I just realized you were being facetious. Facetiousness and sarcasm always gets me.
ps. You know the drill.
I saw what Alabama responded, and he is correct. Turkey was supposed to add diversity to the mix. Revive followed what big pharmacy did with their trials. Anyway, we move forward as the hospitalizations declined and the variants changed. Heck- Let's just unblind the whole thing. We could have done that in two weeks. I guess we wait for the gurus to decide our fate. Cheers.
ps. You know the deal.
One fellow, elsewhere, speculated that Michael Frank was waited to include this published article with his submission. hmmm
There is no data. Revive never dosed one patient in Turkey.
This is the lowest volume I have seen ever. Most of us have more share than were traded all day. lol.
ps. You know the drill.
It reminds me of an old Langston Hughes poem. If this dream becomes reality, our lives will change. The problem is with this stock, I age two years for every one year, so I may be dead before I see any profits. Oh well, I have a 24 year old warrior daughter who will be sitting pretty.
ps. We wait.
As you know, Monkeypox and HIV are primarily found in the gay community.
ps. If Revive wasn't involved in this phase 3 trial, I wonder how many updates we would have received on the psychedelic side. Derrick must have some sh-tload of information based on magic mushrooms, oral strips, and cancer research that MF is holding.
pps. I am interested to hear the feedback from those who attend the annual meeting in late September.
ppps. I can carry a lot of stuff. I may need your help with the water cooler. MF will likely move it fully loaded to save money.
If he is married, I think you mean husband.
On the bright side, he didn't get hit by a bus.
Thank you for this post. So if Pfizer has to do a trial for long haulers, then Revive will need to do one as well if they want to be considered as a solution for long haulers.
"There are several 'smarter than me' posters here so your suggestions will be appreciated, especially if you have one for the new variants."
Thanks for acknowledging my intelligence, although you neglected to mention me by name. I will just assume you meant me. Actually, the only things I am good at are lifting things, having a good work ethic, being punctual, and having above average grammar skills. Revive has made me pretty good at waiting too.
ps. You got me on Vitamin D3, garlic, and I added fish oil. My body doesn't do well with magnesium, and I haven't tried zinc although I get some with a multivitamin.
pps. Let's go. (before someone else does)
I thought he had only a one story house.
Who is up for another trial for long haulers? It's time to get some help from the big boys. Let's see what is doing with the symptoms for 210.
I hope your investment plan is better than your attempt to imitate Shakespeare. :)
Today pissed me off. I'm not going to lie. I lost a ton of money on paper, and it puts me in a foul mood. I will not post for a few days while I stew.
I hope everyone is holding and buying the dips. I am all tapped out. Time will tell. What's another few weeks as we wait for our destiny?
GLTA
ps. I hope MF doesn't turn out to be the court jester.
Now that is a trial that would be very interesting. A buddy of mine has long haulers,and he just puked all over himself after drinking spoiled milk. He couldn't taste it. Plus, it he is a shell of the person he used to be. I mean, not like an Alzheimer's patient, but the brain fog literally affects his thinking, and he is slow to pick up on subtle humor, and he says affects his work too that. I am beginning to become concerned about his safety.
ps. We wait.
I appreciate your response, but I think it will be shorter than that for the next step I hope I am right. So do you.
Your previous post is unclear. Lake?
This may be true, so let's unblind the rest when the dosage increased. The results will be even better.
Close the account. I have spent too many hours on this channel already. It's like a train wreck. My favorites were the jelly donuts.
So endpoints change and we wait some more. Can we just fast forward another month as we bleed slowly and wait for submission?
ps. Ugh. That's my new mantra.
pps. We wait. That's my old mantra.
Thanks for the post. It makes me more optimistic than ever.
ps. I thought I had a lot of shares of Bucy. His number is ridiculous.
Put me down for that.
ps. I was riding on I95, and I saw a U Haul broken down. I had to look. The driver was walking around, and he was not wearing sweatpants. I repeat, he was not wearing sweatpants. Therefore, I conclude all is well. Enough due diligence for today. I will take a nap now and wait.
pps. yes, he was wearing pants at least.
I am not going to lie. Today was annoying as hell. Let's see those sweatpants soon or at least hear from the big guy. One way or another as Clint Eastwood fans would recall, " I gots to know."
ps. We wait.
I blame it on the Woke Culture. Let's go. It can't be long now.
Something big must be brewing because this is taking too long, I have a vast background in medicinal trial research statistical analysis, and I am considering each day we delay a blessing in disguise. I hope we will be rewarded for waiting and patience. GLTA.
ps. I had no idea a woman read these posts and for that matter, even commented here. I apologize for sharing all the stories about my cruel and evil female boss many months ago. I have matured since then. I hope you didn't see them.
pps. Al right I will come clean. I know nothing about nothing, but I have a hunch and know people who have done their DD and with a little bit of luck, we may have something here. We wait.
Plan B? Jenny McCarthy selling Bucy for weight loss? lol
ps. We wait.
Where is our lobbyist? Is he awaiting the 210 too? This seems quite big especially with its safety record.
Statistician must have noticed some trends. Hopefully, all is well.
ps. We are still up 100%, Gator. Slap a tomato on your sandwich tomorrow.
Yes. Number one on the docket is to find the uhaul truck with the humidor cabinet and water cooler which seems to have stalled somewhere around the border. Like Eco, I don't put too much weight on these meetings.
All that matters is the data and selling some of this stuff. With the hospitalizations increasing, we may need to unblind another 500 patients. I just hope there is no need to open up Turkey or continue the trials. Hopefully, 750 is enough, even without diversity.
ps. As we know, a few cents is meaningless if investors balk at the delay of the meeting. It will recover soon enough is all is well like we assume.
pps. Do statisticians work over the weekend? I sure hope so.